Oncology Experts

T. Hercend

finance and restructuring operations


Thierry Hercend, M.D., Ph.D. , has over 30 years of experience in both academia and  the  pharmaceutical  industry,  in  various  therapeutic  areas  including  oncology  and  inflammatory diseases. Since 2006, Thierry Hercend has held the position of  Venture  Partner  at  Edmond  de  Rothschild  Investment Partners  (EdRIP).  From  2002 to  2005,  Thierry Hercend was Vice President in charge of the oncology therapeutic area at Aventis. From 1998  to 2002, he was Vice President of Research, Europe at Vertex Pharmaceuticals. Dr. Hercend joined the  pharmaceutical  industry  in  1990  as  director of the  immunology therapeutic  area  and  then scientific  director of the healthcare division at Roussel - Uclaf. Prior to joining the pharmaceutical industry, Dr. Hercend was Head of  the Hemato - Immunology Unit  of the Gustave Roussy Cancer Institute, Villejuif, France, Director of Inserm Unit U333 with a focus on  tumor immunology and Professor of Immunology at the Medical Faculty of Paris XI University.  Thierry  Hercend  has  authored  more  than  120  publications  in  oncology,  autoimmune  diseases  and  transplantation.

Research Interest

oncology,  autoimmune  diseases  and  transplantation.

Global Experts from France

Global Experts in Subject

Share This Profile
Recommended Conferences